Is my participation confidential?
Your participation in this study is completely confidential. All participants will be identified with a study ID number for complete confidentiality. Any information you provide us will be in a secure and encrypted database and de-identified.
Is my participation voluntary?
Yes. The study is completed voluntarily; you may leave this study at any time. We will provide a consent form for you to review and sign. We encourage you to take your time to review it and ask the staff any questions you may have. Note about informed consent: Consent means that you give someone permission to do something. Consent is NOT just a form — it's a full and ongoing conversation. The research team must explain everything about the study and tell you about other options. They have to explain in a way you can understand. No one is allowed to force or trick you into giving permission for a research study.
Do I have to purchase materials to participate in this study?
Participants will not need to purchase anything for participation in this study. All study materials will be provided and shipped by the staff.
What are the next steps after I screen for the study?
A member of our staff will schedule you for the first of two (2) intake appointments. You will then have your second intake appointment with a study physician. If you are eligible, you will then begin weekly visits.
What is the timeframe of the study?
The study is 12 weeks consisting of two (2) intake appointments and weekly visits twice a week for one (1) hour each.
What type of compensation will I receive for participating in this study?
We are offering monetary compensation of approximately $1,000.
How will the study benefit me and other women like me?
As a research study there is no immediate direct benefit to the participant. A participant may be placed on the study medication, guanfacine or a placebo. Your participation in this study can potentially lead to the development of better- tailored treatment for substance using women. To date, there are no FDA-approved medications for substance use and there are no other studies focused on developing medication specifically for substance using women.
What’s involved in the study?
Coronavirus Update: Participants can now fully participate in the study remotely through Zoom. All study materials needed and study medication will be shipped to the participant’s location.
This study is 12 weeks long. There are two (2) to three (3) initial intake visits that are approximately two (2) to (3) hours long. We will then meet with you two (2) times a week for approximately one (1) hour for the next 10 weeks. These visits will include medication management, counseling and overall monitoring and assessments. You will be randomized to be put on either guanfacine or placebo.
